Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
American Journal of Pharmaceutical Education
|
November 7, 2012
Report of the 2011-2012 AACP Special Advisory Committee on Research and Graduate Education
Yuen-Sum Lau, Robert Blouin, Diana Brixner, et al.
European Journal of Clinical Pharmacology
|
June 11, 2017
The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies
Casey R Tak, Kathleen M Job, Katie Schoen-Gentry, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 27, 2023
Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment
Rupesh Panchal, Danielle Nguyen, Priyanka Ghule, et al.
Cancer Research Communications
|
March 24, 2026
Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United States
Chia Jie Tan, Connor Willis, Timothy Bell, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 10, 2018
Guidance toward the implementation of multicriteria decision analysis framework in developing countries
András Inotai, Huong Thanh Nguyen, Budi Hidayat, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 26, 2018
Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective
Rohit Mistry, Jessica R May, Gaurav Suri, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 28, 2016
Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up
Jill Augustine, Terri L Warholak, Lisa E Hines, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 27, 2024
Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis
Anindit Chhibber, Alexandre Hikiji Watanabe, Hollyann Jacobs, et al.
Current Medical Research and Opinion
|
July 24, 2018
Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer
Rohit Mistry, Gaurav Suri, Kate Young, et al.
JCO Precision Oncology
|
March 25, 2026
Real-World Study Assessing Characteristics and Treatment Patterns of Patients With Human Epidermal Growth Factor Receptor 2 Immunohistochemistry 0 and Human Epidermal Growth Factor Receptor 2-Low Stage IV Breast Cancer: A Multicenter Retrospective Study
Chia Jie Tan, Connor Willis, Trang Au, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
American Journal of Pharmaceutical Education
|
November 7, 2012
Report of the 2011-2012 AACP Special Advisory Committee on Research and Graduate Education
Yuen-Sum Lau, Robert Blouin, Diana Brixner, et al.
European Journal of Clinical Pharmacology
|
June 11, 2017
The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies
Casey R Tak, Kathleen M Job, Katie Schoen-Gentry, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 27, 2023
Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment
Rupesh Panchal, Danielle Nguyen, Priyanka Ghule, et al.
Cancer Research Communications
|
March 24, 2026
Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United States
Chia Jie Tan, Connor Willis, Timothy Bell, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 10, 2018
Guidance toward the implementation of multicriteria decision analysis framework in developing countries
András Inotai, Huong Thanh Nguyen, Budi Hidayat, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 26, 2018
Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective
Rohit Mistry, Jessica R May, Gaurav Suri, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 28, 2016
Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up
Jill Augustine, Terri L Warholak, Lisa E Hines, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 27, 2024
Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis
Anindit Chhibber, Alexandre Hikiji Watanabe, Hollyann Jacobs, et al.
Current Medical Research and Opinion
|
July 24, 2018
Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer
Rohit Mistry, Gaurav Suri, Kate Young, et al.
JCO Precision Oncology
|
March 25, 2026
Real-World Study Assessing Characteristics and Treatment Patterns of Patients With Human Epidermal Growth Factor Receptor 2 Immunohistochemistry 0 and Human Epidermal Growth Factor Receptor 2-Low Stage IV Breast Cancer: A Multicenter Retrospective Study
Chia Jie Tan, Connor Willis, Trang Au, et al.
Page
of 11